Phibro Animal Health Corp (NASDAQ:PAHC)
| 9.88 Delayed Data As of Dec 01 |  +0.29 / +3.02%Today’s Change | 9.40 Today|||52-Week Range 16.52 | -26.32% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Pharmaceuticals: Major | MARKET CAP $399.8M |
Company Description
Phibro Animal Health Corp. engages in the development, manufacture, and marketing of animal health and mineral nutrition products. It operates through the following segments: Animal Health, Mineral Nutrition, and Performance Products. The Animal Health segment develops and markets medicated feed additives, nutritional specialty products, and vaccines. The Mineral Nutrition segment includes formulations and concentrations of trace minerals such as zinc, manganese, copper, iron, and compounds. The Performance Products segment produces specialty ingredients for use in the personal care, automotive, industrial chemical, and chemical catalyst industries. The company was founded on May 11, 1946 and is headquartered in Teaneck, NJ.
Contact Information
Phibro Animal Health Corp. Glenpointe Centre East Teaneck New Jersey 07666-6712 |
Employees
Shareholders
| Individual stakeholders | 9.04% |
| Other institutional | 50.12% |
| Mutual fund holders | 49.44% |
Top Executives
| Jack C. Bendheim | Chairman, President & Chief Executive Officer |
| Larry L. Miller | Chief Operating Officer |
| Richard G. Johnson | Chief Financial Officer |
| Judith A. Weinstein | Secretary, Senior Vice President & General Counsel |
| Mona Desai | Vice President & Controller |
